Browse by Title

Type here to filter the list

M
Machine Learning for Developing Interpretable Population PK Models
Favorite

Damilola O. Olabode, PhD (she/her/hers) – Quantitative Clinical Pharmacology, AstraZeneca ### 2360674###Speaker###Associate Director###Quantitative Clinical Pharmacology, AstraZeneca###
Speaker: Damilola O. Olabode, PhD (she/her/hers) – Quantitative Clinical Pharmacology, AstraZeneca
### she/her/hers
Mapping Longitudinal Biomarker Relationships in Alzheimer’s Disease with Latent Time Joint Mixed Effects Modeling
Favorite

Seth Robey, PhD (he/him/his) – Merck & Co., Inc. ### 2360720###Speaker###Director, Quant. Pharmacology & Pharmacometrics###Merck & Co., Inc.###
Speaker: Seth Robey, PhD (he/him/his) – Merck & Co., Inc.
### he/him/his
Mechanisms that drive E-R confounding for large and small molecules: do we need to understand these to address E-R confounding in our analyses?
Favorite

Mitch Phelps, PhD (he/him/his) – The Ohio State University ### 2360708###Speaker###Professor, College of Pharmacy###The Ohio State University###
Speaker: Mitch Phelps, PhD (he/him/his) – The Ohio State University
### he/him/his
Mechanistic physiologically-based pharmacokinetic models for optimal development of bi-specific T cell engagers
Favorite

Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen ### 2384744###Speaker###Principal Scientist###Clinical Pharmacology Modeling & Simulation, Amgen###
Speaker: Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen
###
Mechanistic QSP modeling for a deeper understanding of ADC toxicities and combination effects with immunotherapies
Favorite

Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group ### 2360701###Speaker###Group leader, Principal scientist I, Translational and Systems Pharmacology###Metrum Research Group###
Speaker: Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group
### she/her/hers
Merging Multimodal with Longitudinal data: Leveraging Graph Neural Networks and Neural-ODEs
Favorite

James Lu, PhD (he/him/his) – Clinical Pharmacology, Genentech Inc. ### 2360670###Speaker###Distinguished AI Scientist###Clinical Pharmacology, Genentech Inc.###
Speaker: James Lu, PhD (he/him/his) – Clinical Pharmacology, Genentech Inc.
### he/him/his
MIDD in the clinical development of gene therapy: from bench to bedside
Favorite

Eleni Caratzas, MSc, PhD – Janssen RnD ### 2384740###Speaker###Senior Scientist ###Janssen RnD ###
Speaker: Eleni Caratzas, MSc, PhD – Janssen RnD
###
Mind the gap – successful bridging of QSP and PMX in drug development
Favorite

Georgi Kapitanov, PhD – Certara ### 2360736###Chair###Senior Director - QSP###Certara###
Chair: Georgi Kapitanov, PhD – Certara
### @@@ Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA ### 2360737###Chair###Vice President, Clinical Pharmacology###Genentech, South San Francisco, CA###
Chair: Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA
### she/her/hers @@@ Mirjam Trame, Ph.D (she/her/hers) – Certara ### 2360657###Speaker###Vice President Pharmacometrics###Certara###
Speaker: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hers @@@ Kapil Gadkar, PhD – Genentech ### 2407912###Speaker###Distinguished Scientist, Senior Director###Genentech###
Speaker: Kapil Gadkar, PhD – Genentech
### @@@ Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA ### 2360738###Speaker###Research Fellow###Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA###
Speaker: Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA
### she/her/hers @@@ C.J. Musante, PhD – Pfizer ### 2407910###Panelist###VP & Global Head of Pharmacometrics & Systems Pharmacology###Pfizer###
Panelist: C.J. Musante, PhD – Pfizer
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###
Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Justin C. Earp, PhD – United States FDA ### 2481300###Panelist###Pharmacometrics Team Lead###United States FDA###
Panelist: Justin C. Earp, PhD – United States FDA
### @@@ Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb ### 2457387###Panelist######Bristol Myers Squibb###
Panelist: Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb
###
Model Informed Drug Development (MIDD) in Alzheimer’s Disease
Favorite

Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company ### 2360719###Speaker###Sr Director, Global PK/PD and Pharmacometrics###Eli Lilly and Company###
Speaker: Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers
Model-based Dose Selection for Epcoritamab, a subcutaneous CD3xCD20 bispecific antibody
Favorite

Tommy Li, PhD – Genmab ### 2360686###Speaker###Director###Genmab###
Speaker: Tommy Li, PhD – Genmab
###
Model-Informed Drug Development Applications to Oncology Bispecifics and Antibody-Drug Conjugates
Favorite

Donghua Yin, PhD – Pfizer ### 2363742###Speaker###Vice President, Head of Clinical Pharmacology, Pfizer Oncology Division###Pfizer###
Speaker: Donghua Yin, PhD – Pfizer
###
Modeling and simulation to support therapy in pregnancy and lactation
Favorite

Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine ### 2407908###Speaker###Professor of OB/GYN###Indiana University School of Medicine###
Speaker: Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine
### she/her/hers
Modeling approaches in pregnancy and lactation for drug development: operational, ethical and regulatory perspectives
Favorite

Karen Rowland Yeo, PhD – Certara UK Ltd ### 2360721###Chair###Senior Vice President###Certara UK Ltd###
Chair: Karen Rowland Yeo, PhD – Certara UK Ltd
### @@@ Priya Jayachandran, PharmD, MSE (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 2360722###Chair###Associate Director, Quantitative Pharmacologist###Regeneron Pharmaceuticals, Inc.###
Chair: Priya Jayachandran, PharmD, MSE (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda ### 2360724###Speaker###Professor of Clinical Pharmacology & Global Health###University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda###
Speaker: Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda
### @@@ Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine ### 2407908###Speaker###Professor of OB/GYN###Indiana University School of Medicine###
Speaker: Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine
### she/her/hers @@@ Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University ### 2360723###Speaker###Professor of Pharmacology, Surgery and Medicine###Thomas Jefferson University###
Speaker: Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University
### he/him/his @@@ Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2360725###Speaker###Clinical Pharmacology Policy Lead ###U.S. Food and Drug Administration###
Speaker: Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University ### 2407905###Speaker###Professor and Chair###Department of Biomedical Informatics, College of Medicine, The Ohio State University###
Speaker: Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University
###
Modeling Delays in Pharmacokinetics and Pharmacodynamics using Phoenix, ISoP MCS SIG
Favorite

Wojciech Krzyzanski, n/a – University at Buffalo ### 2343534###Speaker###Associate Professor###University at Buffalo###
Speaker: Wojciech Krzyzanski, n/a – University at Buffalo
### @@@ Shuhua Hu, PhD – Certara ### 2343535###Speaker###Principal Research Scientist###Certara###
Speaker: Shuhua Hu, PhD – Certara
###